These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12141412)

  • 61. Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.
    Ahya VN; McShane PJ; Baz MA; Valentine VG; Arcasoy SM; Love RB; Seethamraju H; Garrity E; Alex CG; Bag R; DeOliveira NC; Vigneswaran WT; Charbeneau J; Krishnan JA; Durazo-Arvizu R; Norwick L; Bhorade S
    J Heart Lung Transplant; 2011 Feb; 30(2):175-81. PubMed ID: 20947384
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk.
    Lee J; Lee JJ; Kim BS; Lee JG; Huh KH; Park Y; Kim YS
    J Korean Med Sci; 2015 Jun; 30(6):682-7. PubMed ID: 26028917
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Thrombotic thrombocytopenic purpura: pathophysiology and treatment].
    Suehiro A
    Rinsho Ketsueki; 2000 Jun; 41(6):463-7. PubMed ID: 10921342
    [No Abstract]   [Full Text] [Related]  

  • 64. Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement.
    Burke GW; Ciancio G; Cirocco R; Markou M; Olson L; Contreras N; Roth D; Esquenazi V; Tzakis A; Miller J
    Transplantation; 1999 Nov; 68(9):1336-42. PubMed ID: 10573073
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Unusual case report of thrombotic microangiopathy of the small bowel following liver transplantation, a possible immunosuppressant-induced disease with histological and ultrastructural findings.
    Piscitelli D; Fiore MG; Rossi R; Casiello M; Sanguedolce F
    ScientificWorldJournal; 2009 Oct; 9():1031-4. PubMed ID: 19802497
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A successful combination of plasma exchange and intravenous cyclophosphamide in a patient with a refractory thrombotic thrombocytopenic purpura.
    Zappasodi P; Corso A; Castagnola C; Tajana M; Lunghi M; Bernasconi C
    Eur J Haematol; 1999 Oct; 63(4):278-9. PubMed ID: 10530421
    [No Abstract]   [Full Text] [Related]  

  • 67. Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome.
    Levi Z; Hazazi R; Kedar-Barnes I; Hodak E; Gal E; Mor E; Niv Y; Winkler J
    Am J Transplant; 2007 Feb; 7(2):476-9. PubMed ID: 17229076
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Potential strategies for the treatment of plasma exchange-resistant thrombotic thrombocytopenic purpura.
    Quintini G; Barbera V; Iannitto E; Mariani G
    Br J Haematol; 2001 May; 113(2):560-2. PubMed ID: 11380435
    [No Abstract]   [Full Text] [Related]  

  • 69. Sirolimus may promote thrombotic microangiopathy.
    Saikali JA; Truong LD; Suki WN
    Am J Transplant; 2003 Feb; 3(2):229-30. PubMed ID: 12603218
    [No Abstract]   [Full Text] [Related]  

  • 70. Probable sirolimus-induced rupture of arterial anastomosis after liver transplantation in a patient intolerant of tacrolimus.
    Lao MY; Ma T; Bai XL; Zhang XZ; Tang TY; Liang TB
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):398-400. PubMed ID: 31053410
    [No Abstract]   [Full Text] [Related]  

  • 71. Management of renal disorders.
    Gilcher RO; Strauss RG; Ciavarella D; Kasprisin DO; Kiprov DD; Klein HG; McLeod BC
    J Clin Apher; 1993; 8(4):258-69. PubMed ID: 8113210
    [No Abstract]   [Full Text] [Related]  

  • 72. Tacrolimus-induced cerebral blindness in a liver transplant patient.
    Tamhankar MA; Lesniak SP; Nallasamy S; Woo JH
    Indian J Ophthalmol; 2016 Jul; 64(7):541. PubMed ID: 23619482
    [No Abstract]   [Full Text] [Related]  

  • 73. Cyclosporine A-associated thrombotic thrombocytopenic purpura following lung transplantation.
    Roberts P; Follette D; Allen R; Katznelson S; Albertson T
    Transplant Proc; 1998 Jun; 30(4):1512-3. PubMed ID: 9636615
    [No Abstract]   [Full Text] [Related]  

  • 74. Phenytoin to expedite sirolimus and tacrolimus elimination.
    Lemke AI; Boilson BA; Razonable RR; Bernard SA
    Clin Transplant; 2022 Dec; 36(12):e14809. PubMed ID: 36063141
    [No Abstract]   [Full Text] [Related]  

  • 75. Lessons for the clinical nephrologist: unexplained tacrolimus overdose in a kidney transplant patient.
    Bacle A; Le Daré B; Vigneau C
    J Nephrol; 2022 Sep; 35(7):1911-1913. PubMed ID: 35286596
    [No Abstract]   [Full Text] [Related]  

  • 76. Hand-foot skin-like reaction associated with tacrolimus therapy in a kidney transplant patient.
    Chen A; Stringer T; Ajaimy M; Kanavy H
    Clin Transplant; 2022 Jul; 36(7):e14693. PubMed ID: 35491540
    [No Abstract]   [Full Text] [Related]  

  • 77. Treatment of aspirin overdose.
    McCarthy LJ; Lister K
    J Clin Apher; 1988; 4(1):50. PubMed ID: 3391989
    [No Abstract]   [Full Text] [Related]  

  • 78. mTOR inhibitors: a myth, a cure for cancer or something in between?
    Wong G; Chapman JR; Craig JC
    Am J Transplant; 2012 May; 12(5):1075-6. PubMed ID: 22537261
    [No Abstract]   [Full Text] [Related]  

  • 79. Tacrolimus and sirolimus: when bad things happen to good drugs.
    Kaplan B; Kirk AD
    Am J Transplant; 2006 Jul; 6(7):1501-2. PubMed ID: 16827845
    [No Abstract]   [Full Text] [Related]  

  • 80. Tacrolimus-induced thrombotic microangiopathy post-liver transplantation for cryptogenic acute liver failure in an infant.
    Wujek C; Fishel Ben-Kenan R; Kothari A; Wadera S; Sacco KA
    Ann Hematol; 2023 Mar; 102(3):687-688. PubMed ID: 36527459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.